This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Jörgen Gustafsson: Innovator in Chemokine Receptor Modulation
Introduction
Jörgen Gustafsson is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate chemokine receptor activity. His work is essential for advancing therapeutic options in various medical conditions.
Latest Patents
Gustafsson holds a patent for "Piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity." This invention provides compounds of general formula (I), which are defined in the specification. The patent outlines processes for their preparation, pharmaceutical compositions containing these compounds, and their therapeutic uses. He has 1 patent to his name.
Career Highlights
Jörgen Gustafsson is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to contribute to innovative research and development in the pharmaceutical industry. His expertise in chemokine receptor modulation is particularly noteworthy.
Collaborations
Gustafsson has collaborated with talented individuals such as Nafizal Hossain and Stinabritt Nilsson. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical sector.
Conclusion
Jörgen Gustafsson's work in the field of chemokine receptor modulation exemplifies the impact of innovative research on therapeutic advancements. His contributions continue to influence the pharmaceutical landscape positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile